Telling stories with omics data

VUGENE is a biomedical data science company specialising in delivering top-level analysis and interpretation, that drive future innovations

Genomics

Our genomics data analysis extracts insights from DNA sequences by identifying and interpreting SNVs, insertions, deletions, and structural variants. Applied to population genetics, rare diseases, and cancer genomics, our analysis aids in developing precise treatments tailored to individual genetic profiles.

Transcriptomics

Our RNA-seq data analysis workflows provide quantification of gene expression, alternative splicing, and other transcribed elements. We tailor statistical analysis to identify differentially expressed elements within even the most complex experimental designs.

Single-cell approaches

Our single-cell data analysis uncovers gene expression and epigenetic landscapes at the individual cell level, providing insights into cellular heterogeneity and disease pathology. It enables identification of rare cell types, tracking cell differentiation pathways, and reveals disease mechanisms.

Epigenomics

Through epigenetic data analysis, DNA methylation, histone modifications, and chromatin accessibility, we uncover modifications that regulate gene expression without altering the DNA sequence, providing critical insights into biological aging, developmental processes and disease mechanisms.

Metabolomics

Metabolomics analysis provides a comprehensive profile of targeted or untargeted metabolites. We identify and quantify metabolites to elucidate their roles in physiological and pathological processes, which helps to uncover disease biomarkers, monitor disease progression, and evaluate the effects of treatments.

Proteomics

Our proteomics data analysis solutions provide a comprehensive examination of the protein landscape. We identify and quantify proteins, reveal their functions, abundance changes and interactions, which are essential for understanding cellular processes, disease progression and developing targeted therapies.

Multi-omics integration

Our multi-omics analysis integrates data from multiple omics experiments, providing a comprehensive view of biological systems. Applying a multi-omics approach accelerates the understanding of complex biological processes, enabling us to discover therapeutic targets, understand disease mechanisms, and develop personalized solutions.

Research areas

If you want to leverage cutting-edge bioinformatics to drive breakthroughs in precision medicine, disease research and therapeutics development, we want to hear from you.

Neurodegeneration

Investigate the molecular mechanisms behind neurodegenerative disorders to uncover new diagnostic and therapeutic targets.

Complex Age-Related
Disorders

We explore the epigenetic factors behind age-related diseases to develop precise tools for measuring the effectiveness of treatments.

Cancer

Our research focuses on using omics data to identify biomarkers and identify potential therapeutic targets for various cancers.

Gene therapy

We explore innovative bioinformatics approaches to facilitate the optimization of gene therapy techniques for treating genetic disorders.

Microbial Genomics

We provide insights into metabolic, immune, and inflammatory pathways, and identify microorganism compositions.

Cardiovascular
Diseases

Our bioinformatics solutions help identify genetic and molecular drivers of cardiovascular diseases, advancing early diagnosis and treatment.

How we work

Let’s start your project together – contact us now

Please describe your research problem and we will get back to you to get things moving forward!

Diverse Expertise, Integrated Solutions
Our interdisciplinary team combines deep biological knowledge with advanced programming skills, delivering a comprehensive approach to every project. We leverage cutting-edge solutions and efficient, proven pipelines to provide fast, high quality insights and results.